C60 Fullerene Prevents Restraint Stress-Induced Oxidative Disorders in Rat Tissues: Possible Involvement of the Nrf2/ARE-Antioxidant Pathway. 2018

Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
Bogomoletz Institute of Physiology, Bogomoletz Str. 4, Kyiv 01024, Ukraine.

The effects of C60FAS (50 and 500 μg/kg) supplementation, in a normal physiological state and after restraint stress exposure, on prooxidant/antioxidant balance in rat tissues were explored and compared with the effects of the known exogenous antioxidant N-acetylcysteine. Oxidative stress biomarkers (ROS, O2·-, H2O2, and lipid peroxidation) and indices of antioxidant status (MnSOD, catalase, GPx, GST, γ-GCL, GR activities, and GSH level) were measured in the brain and the heart. In addition, protein expression of Nrf2 in the nuclear and cytosol fractions as well as the protein level of antiradical enzyme MnSOD and GSH-related enzymes γ-GCLC, GPx, and GSTP as downstream targets of Nrf2 was evaluated by western blot analysis. Under a stress condition, C60FAS attenuates ROS generation and O2·- and H2O2 releases and thus decreases lipid peroxidation as well as increases rat tissue antioxidant capacity. We have shown that C60FAS supplementation has dose-dependent and tissue-specific effects. C60FAS strengthened the antiradical defense through the upregulation of MnSOD in brain cells and maintained MnSOD protein content at the control level in the myocardium. Moreover, C60FAS enhanced the GSH level and the activity/protein expression of GSH-related enzymes. Correlation of these changes with Nrf2 protein content suggests that under stress exposure, along with other mechanisms, the Nrf2/ARE-antioxidant pathway may be involved in regulation of glutathione homeostasis. In our study, in an in vivo model, when C60FAS (50 and 500 μg/kg) was applied alone, no significant changes in Nrf2 protein expression as well as in activity/protein levels of MnSOD and GSH-related enzymes in both tissues types were observed. All these facts allow us to assume that in the in vivo model, C60FAS affects on the brain and heart endogenous antioxidative statuses only during the oxidative stress condition.

UI MeSH Term Description Entries
D008297 Male Males
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013315 Stress, Psychological Stress wherein emotional factors predominate. Cumulative Stress, Psychological,Emotional Stress,Individual Stressors,Life Stress,Psychological Cumulative Stress,Psychological Stress Experience,Psychological Stress Overload,Psychologically Stressful Conditions,Stress Experience, Psychological,Stress Measurement, Psychological,Stress Overload, Psychological,Stress Processes, Psychological,Stress, Emotional,Stressful Conditions, Psychological,Psychological Stress,Stress, Psychologic,Stressor, Psychological,Condition, Psychological Stressful,Condition, Psychologically Stressful,Conditions, Psychologically Stressful,Cumulative Stresses, Psychological,Experience, Psychological Stress,Individual Stressor,Life Stresses,Measurement, Psychological Stress,Overload, Psychological Stress,Psychologic Stress,Psychological Cumulative Stresses,Psychological Stress Experiences,Psychological Stress Measurement,Psychological Stress Measurements,Psychological Stress Overloads,Psychological Stress Processe,Psychological Stress Processes,Psychological Stresses,Psychological Stressful Condition,Psychological Stressful Conditions,Psychological Stressor,Psychological Stressors,Psychologically Stressful Condition,Stress Experiences, Psychological,Stress Processe, Psychological,Stress, Life,Stress, Psychological Cumulative,Stressful Condition, Psychological,Stressful Condition, Psychologically,Stressor, Individual
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051267 NF-E2-Related Factor 2 A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage. Nfe2l2 Protein,Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein,Nuclear Factor E2-Related Factor 2,NF E2 Related Factor 2,Nuclear Factor E2 Related Factor 2

Related Publications

Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
August 2019, Journal of Asian natural products research,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
January 2020, Frontiers in pharmacology,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
February 2022, Free radical biology & medicine,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
January 2014, International journal of nanomedicine,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
July 1998, Chemico-biological interactions,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
February 2024, Cell death discovery,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
January 2008, Journal of biochemical and molecular toxicology,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
January 2017, Molecular neurobiology,
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
September 2021, Environmental pollution (Barking, Essex : 1987),
Olga O Gonchar, and Andriy V Maznychenko, and Nataliya V Bulgakova, and Inna V Vereshchaka, and Tomasz Tomiak, and Uwe Ritter, and Yuriy I Prylutskyy, and Iryna M Mankovska, and Alexander I Kostyukov
June 2005, Current drug targets. CNS and neurological disorders,
Copied contents to your clipboard!